Table 2 CSR activities by pharmaceutical firm

Donation

X

X

X

X

X

Differential pricing sales for resource poor countries

X

X

X

X

X

X

Special licensing agreements for resource-poor countries

X

X

X

X

Training of health care workers

X

X

X

X

Improved local manufacturing

X

X

X

Increased product distribution capacity

X

X

X

X

X

X

Infrastructure investment

X

X

X

Supply-chain support

X

X

X

X

Private or informal provider engagement

X

X

X

X

X

Promoting uptake of health insurance

X

X

Loan & Microfinance programs

X

X

X

mHealth initiatives

X

X

X

X

X

Social marketing

X

Health issue awareness campaigns

X

X

X

X

Advocacy and policy

X

Targeted Research & Development*

X

X

X

X

X

X

International employee placement program

X

X

X

X